Amgen nears deal to acquire Horizon Therapeutics, WSJ reports

Amgen (AMGN) is in advanced talks to buy drug company Horizon Therapeutics (HZNP) in a takeover likely to be valued at well over $20 billion and mark the largest healthcare merger of the year, The Wall Street Journal’s Ben Dummett, Dana Cimilluca, and Laura Cooper report, citing people familiar with the matter. A deal could be finalized by Monday assuming the talks with Amgen don’t fall apart, the people said. Reference Link